Engineering nano‐clustered multivalent agonists to cross‐link TNF receptors for cancer therapy
Cited by 14
Related Papers
Immunomodulating nano-adaptors potentiate antibody-based cancer immunotherapy
|Nature Communications|2021|108
Dexmedetomidine attenuates repeated propofol exposure-induced hippocampal apoptosis, PI3K/Akt/Gsk-3β signaling disruption, and juvenile cognitive deficits in neonatal rats
|Molecular Medicine Reports|2016|64
Engineering tumor-specific gene nanomedicine to recruit and activate T cells for enhanced immunotherapy
|Nature Communications|2023|60
Targeting nicotinamide N-methyltransferase overcomes resistance to EGFR-TKI in non-small cell lung cancer cells
|Cell Death Discovery|2022|21